InsidersTradesSigma
Total declarations
Company
▲ Purchases (16 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Elie FRAENCKEL, Director. Insider active across 1 companies, notably BIOSYNEX. Cumulatively, 19 filings have been recorded. Total volume traded: €464k. The latest transaction was filed on 14 February 2025 — Souscription. Regulator: AMF. The full history is openly available.
Declarations19 total
€13,83213,832 shares@ €1.0095.8% of flow
ActionEuronext Growth Paris
2025DD1020943·
€49410,975 shares@ €0.0450.0027% mcap3.4% of flow
DPSEuronext Growth Paris
2025DD1018760·
€1171,000 shares@ €0.11720.0007% mcap0.8% of flow
DPSEuronext Growth Paris
2025DD1017643·
€30,5052,500 shares@ €12.20190.17% mcap6.6% of flow
ActionEuronext Growth Paris
2023DD884526·
Ideal exit: 7 Nov 2023 (T+270)
€30,6752,500 shares@ €12.27010.17% mcap6.6% of flow
ActionEuronext Growth Paris
2023DD884527·
Ideal exit: 10 Nov 2023 (T+270)
€17,4711,000 shares@ €17.47090.097% mcap3.8% of flow
ActionEuronext Growth Paris
2022DD822689·
Ideal exit: 19 Nov 2022 (T+270)
€17,6451,000 shares@ €17.64540.098% mcap3.8% of flow
ActionEuronext Growth Paris
2022DD822659·
Ideal exit: 19 Nov 2022 (T+270)
€1,13165 shares@ €17.400.0063% mcap0.2% of flow
ActionEuronext Growth Paris
2022DD822669·
Ideal exit: 19 Nov 2022 (T+270)
€17,4191,000 shares@ €17.41890.097% mcap3.8% of flow
ActionEuronext Growth Paris
2022DD822648·
Ideal exit: 19 Nov 2022 (T+270)
€17,3741,000 shares@ €17.37350.097% mcap3.7% of flow
ActionEuronext Growth Paris
2022DD822649·
Ideal exit: 19 Nov 2022 (T+270)
€17,4171,000 shares@ €17.41660.097% mcap3.8% of flow
ActionEuronext Growth Paris
2022DD822654·
Ideal exit: 19 Nov 2022 (T+270)
€16,7461,000 shares@ €16.74620.093% mcap3.6% of flow
ActionEuronext Growth Paris
2022DD820969·
Ideal exit: 7 Nov 2022 (T+270)
€16,7801,000 shares@ €16.780.093% mcap3.6% of flow
ActionEuronext Growth Paris
2022DD820965·
Ideal exit: 7 Nov 2022 (T+270)
€16,7471,000 shares@ €16.74670.093% mcap3.6% of flow
ActionEuronext Growth Paris
2022DD820968·
Ideal exit: 7 Nov 2022 (T+270)
€18,9231,000 shares@ €18.92320.11% mcap4.1% of flow
ActionEuronext Growth Paris
2021DD811810·
Ideal exit: 4 Sept 2022 (T+270)
€48,0002,000 shares@ €24.000.27% mcap10.4% of flow
ActionEuronext Growth Paris
2021DD758770·
Ideal exit: 28 Feb 2022 (T+270)
€48,4762,000 shares@ €24.23780.27% mcap10.5% of flow
ActionEuronext Growth Paris
2021DD746002·
Ideal exit: 18 Jan 2022 (T+270)
€48,2002,000 shares@ €24.100.27% mcap10.4% of flow
ActionEuronext Growth Paris
2021DD742598·
Ideal exit: 18 Jan 2022 (T+270)
€99,9524,000 shares@ €24.98790.56% mcap21.6% of flow
ActionEuronext Growth Paris
2021DD742006·
Ideal exit: 14 Jan 2022 (T+270)
19 of 19 declarations
About Elie FRAENCKEL
Elie FRAENCKEL is an executive at BIOSYNEX.
